Additional information
White Powder
70359-46-5
ACI-020800
205.8-206.0°C
C15H16BrN5O6
442.22
Ambient
2-8°C
ocular hypertension
Pharmacopeial Reference Standards
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl) -6-quinoxalinamine tartrate
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate
Brimonidine L-Tartrate;6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate